Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 3.95B |
| Enterprise Value | 4.54B |
| P/E Ratio | -11.11 |
| PEG Ratio | 0.08 |
| Price/Sales Ratio | 4.03 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 4.7 |
| Enterprise/EBITDA | -26.82 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.36 |
| Operating Margin | -0.38 |
| Return On Assets | -0.09 |
| Return On Equity | -0.16 |
| Revenue | 789.42M |
| Revenue/Share | 2.54 |
| Gross Profit | 297.81M |
| EBITDA | -183.87M |
| Net Income | -339.63M |
| Diluted EPS | -1.07 |
| Total Cash | 386.7M |
| Total Cash/Share | 1.22 |
| Total Debt | 892.7M |
| Total Debt/Equity | 0.52 |
| Current Ratio | 0.72 |
| Book Value Per Share | 5.47 |
| 52-Week Change | -29.84 |
| 52-Week High | 17.19 |
| 52-Week Low | 8.93 |
| Moving Average 50 Days | 12.76 |
| Moving Average 200 Days | 11.79 |
| Average Volume | 23.2M |
| Shares Outstanding | 316.35M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.08 |
| Last Split Factor | 3:2 |
| Last Split Date | June 13, 2018 |